A Retrospective Study of Tinea Capitis Management in General Pediatric Clinics and Pediatric Emergency Departments at 2 US Centers

J Pediatr. 2021 Jul:234:269-272. doi: 10.1016/j.jpeds.2021.03.051. Epub 2021 Mar 29.

Abstract

We examine management practices of tinea capitis at 2 US academic centers. The majority of providers treated tinea capitis with the oral antifungal agent griseofulvin and did not obtain a fungal culture. We recommend newer antifungal treatments such as terbinafine and fluconazole and obtaining a fungal culture for effective treatment.

Keywords: fluconazole; griseofulvin; itraconazole; management; prescription; terbinafine; tinea capitis; treatment.

Publication types

  • Multicenter Study

MeSH terms

  • Academic Medical Centers
  • Adolescent
  • Antifungal Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Emergency Service, Hospital
  • Female
  • Fluconazole / therapeutic use
  • Griseofulvin / therapeutic use
  • Humans
  • Male
  • Pediatrics
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Retrospective Studies
  • Terbinafine / therapeutic use
  • Tinea Capitis / diagnosis*
  • Tinea Capitis / drug therapy*
  • United States

Substances

  • Antifungal Agents
  • Griseofulvin
  • Fluconazole
  • Terbinafine